Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J's Vitros Lab Diagnostics Systems Expand Market Access, Drive Sales

This article was originally published in The Gray Sheet

Executive Summary

Ortho-Clinical Diagnostics' Vitros 5600 and Vitros 3600 next-generation laboratory diagnostic systems will double the size of the market the Johnson & Johnson division addresses from $4.6 billion to $9.8 billion, according to the company

You may also be interested in...



J&J/DePuy's Ceramic-On-Metal Hip Is Approvable With Conditions - Panel

Johnson & Johnson/DePuy's CoMplete ceramic-on-metal acetabular hip system should be approved by FDA, according to the agency's Orthopedic and Rehabilitation Devices Panel

J&J’s Computer-Assisted Sedation System Gets FDA Panel Nod

Ethicon Endo-Surgery's Sedasys computer-assisted personalized sedation system should be approved by FDA, as long as labeling requires a three-person team to be present during its use, according to the agency's Anesthesiology and Respiratory Therapy Devices panel

J&J’s Vitros 5600 system receives 510(k)

Ortho-Clinical Diagnostics, a Johnson & Johnson company, plans in the fourth quarter to launch its Vitros 5600 next-generation laboratory diagnostics system, following receipt of 510(k) clearance Oct. 24. The device integrates clinical chemistry and immunoassay testing while incorporating "innovations" such as "sample-centered" processing and a small footprint, the firm explains. It can perform more than 100 different chemistry, immunoassay and infectious disease assays

Related Content

Topics

UsernamePublicRestriction

Register

MT028058

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel